Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Lumexa Imaging HoldingsLMRI +4.87%9 EV-to-OCF is 104.62 as of Aug. 13, 2026, which is 62% below its 10-year median of 275.57. GuruFocus rates LMRI with a GF Score™ of 9/100. The stock has 2 warning signs investors should review. Among 853 Medical Devices & Instruments companies, Lumexa Imaging Holdings ranks worse than 94.96% on this metric.
EV-to-OCF is calculated as enterprise value divided by its cash flow from operations. As of today, Lumexa Imaging Holdings's Enterprise Value is $2,096.1 Mil.
Lumexa Imaging Holdings's Cash Flow from Operations for the trailing twelve months (TTM) ended in Mar. 2026 was $20.0 Mil. Therefore, Lumexa Imaging Holdings's EV-to-OCF for today is 104.62.
The historical rank and industry rank for Lumexa Imaging Holdings's EV-to-OCF or its related term are showing as below:
LMRI'
s EV-to-OCF Range Over the Past 10 Years
Min: 58.08 Med: 275.57 Max: 347.32
Current: 104.62
During the past 3 years, the highest EV-to-OCF of Lumexa Imaging Holdings was 347.32. The lowest was 58.08. And the median was 275.57.
LMRI's EV-to-OCF is ranked worse than 94.96% of 853
companies
in the Medical Devices & Instruments industry
Industry Median: 7.88
vs LMRI: 104.62
EV-to-OCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
EV-to-OCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
Lumexa Imaging Holdings's PE Ratio (TTM) for today is calculated as:
Lumexa Imaging Holdings's share price for today is $12.28.
Lumexa Imaging Holdings's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $-0.360.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Cash Flow from Operations is an important financial metric because it represents the cash generated from operating activities at a company's disposal. Companies with a low EV-to-OCF ratio, combined with a strong balance sheet are generally considered as undervalued.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Devices subindustry, Lumexa Imaging Holdings's EV-to-OCF, along with its competitors' market caps and EV-to-OCF data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Lumexa Imaging Holdings EV-to-OCF vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Lumexa Imaging Holdings's EV-to-OCF distribution charts can be found below:
* The bar in red indicates where Lumexa Imaging Holdings's EV-to-OCF falls into.
Lumexa Imaging Holdings's current Enterprise Value is $2,096.1 Mil.
Lumexa Imaging Holdings's Cash Flow from Operations for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $20.0 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Lumexa Imaging Holdings (LMRI) has a EV-to-OCF of 104.62 as of Aug. 13, 2026. This is 62% below median its historical median of 275.57. Over the past decade, Lumexa Imaging Holdings' EV-to-OCF has ranged from 58.08 to 347.32. According to the industry distribution chart, Lumexa Imaging Holdings ranks #810 out of 853 companies in the Medical Devices & Instruments industry, placing it in the top 95%.
Is Lumexa Imaging Holdings' EV-to-OCF too high?
Lumexa Imaging Holdings' current EV-to-OCF of 104.62 is 62% below median its 10-year median of 275.57. Over the past 10 years, this metric has ranged from a low of 58.08 to a high of 347.32. The Medical Devices & Instruments industry median EV-to-OCF is 7.88. Lumexa Imaging Holdings' value of 104.62 is 1227.7% above this industry median. Based on the distribution chart, Lumexa Imaging Holdings ranks #810 out of 853 companies in the Medical Devices & Instruments industry, which is in the bottom quartile relative to peers. Overall, Lumexa Imaging Holdings has a GF Score™ of 9/100, reflecting its overall financial health beyond just this single metric.
How does Lumexa Imaging Holdings' EV-to-OCF compare to QDEL and PRCT?
According to the Medical Devices & Instruments industry distribution chart, Lumexa Imaging Holdings ranks #810 out of 853 companies for EV-to-OCF. This places Lumexa Imaging Holdings in the lower half of its industry. The industry median EV-to-OCF is 7.88. Lumexa Imaging Holdings' value of 104.62 is 1227.7% above this benchmark. Historically, Lumexa Imaging Holdings' own EV-to-OCF has ranged from 58.08 to 347.32 over the past decade. While the company's 10-year median is 275.57 vs. the industry median of 7.88, Lumexa Imaging Holdings has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-OCF for a Medical Devices & Instruments company?
The median EV-to-OCF among Medical Devices & Instruments companies is 7.88, based on 853 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-OCF significantly above this median, while those in the bottom quartile fall well below. However, EV-to-OCF should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Lumexa Imaging Holdings's current EV-to-OCF of 104.62 is 1227.7% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-OCF mean?
A high EV-to-OCF can signal that a stock is expensive relative to its fundamentals. For the Medical Devices & Instruments industry, the median EV-to-OCF is 7.88 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Lumexa Imaging Holdings's current EV-to-OCF is 104.62, which is 62% below median its own 10-year median of 275.57. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Lumexa Imaging Holdings stock overvalued right now?
Lumexa Imaging Holdings (LMRI) has a current EV-to-OCF of 104.62. The current EV-to-OCF is 104.62, which is 62% below median its 10-year median of 275.57 and 1227.7% above the Medical Devices & Instruments industry median of 7.88. Lumexa Imaging Holdings' overall GF Score™ is 9/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-OCF calculated?
EV-to-OCF is calculated from a company's financial statements. For Lumexa Imaging Holdings (LMRI), the current EV-to-OCF is 104.62 as of Aug. 13, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Lumexa Imaging Holdings Inc is a provider of diagnostic imaging services. The company offers a broad range of imaging modalities, including MRI, CT, PET, X-ray, ultrasound, and mammography. Its products and operations are managed and reported in two operating segments: Outpatient Imaging Centers (Outpatient) and Professional Services (Professional). The professional services segment generates revenue from interpreting imaging studies conducted by other parties, mainly hospital imaging departments. The majority of revenue is generated by the Outpatient segment, which performs imaging studies and provides radiologists' interpretations of those studies.
9GF Score
Get the complete analysis for LMRI
EV-to-OCF is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
LMRI has been successfully added to your 
